Metraipolis › archive › dc_a862accc5ecf

COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden — Europe PMC PMID:41526539

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41526539
DOI
10.1038/s41598-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-06T21:45:24.701Z
SHA-256 of the archived text
fe958f22b1e55377b809911f3d3ca103d953cc03bdad6e811d520910c718d859
Stable URL of this page
https://metraipolis.com/documento/dc_a862accc5ecf

How to cite

COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden — Europe PMC PMID:41526539 — Europe PMC (en), https://europepmc.org/article/MED/41526539 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a862accc5ecf (Metraipolis archive dc_a862accc5ecf, sha256 fe958f22b1e55377b809911f3d3ca103d953cc03bdad6e811d520910c718d859)
BibTeX
@misc{dca862accc5ecf,
  title = {COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden — Europe PMC PMID:41526539},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41526539},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a862accc5ecf; sha256 fe958f22b1e55377b809911f3d3ca103d953cc03bdad6e811d520910c718d859},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41526539. Agents can read the archived copy with the MCP tool read_document.